Tag: Vaccine production

NANOLEK began industrial production of the CoviVac vaccine

NANOLEK announced the launch of industrial production of CoviVac. Investments in this project amounted to 40 million rubles, the...

South Korea aims to make vaccine industry more competitive with emphasis on COVID-19

South Korea has recently unveiled a US$2bn plan to emerge as a global COVID-19 vaccine production hub and become one of the top five manufacturing bases by 2025.

Hanmi Science has completed the development of six types of raw materials for mRNA vaccines

Hanmi Science has formed a consortium with ST Pharm and GC Green Cross to secure and commercialize domestic mRNA vaccine technology by 2022.

Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing

The collaboration aims to provide Canadians with access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses, including COVID-19, seasonal influenza...

Laboratorios Richmond delivers the first batch of over 1M doses of the Sputnik V produced in Argentina

Locally produced Sputnik V was supervised and verified by the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT).

Petrovax to manufacture up to 10 mln doses of China’s Convidencia a month

The company said earlier that it planned to commission its Convidencia full cycle production line by the end of 2021.

Laboratorios Richmond to provide with over 3 million doses of the second component of the Sputnik V vaccine

RDIF and partners facilitated the technology transfer to Laboratorios Richmond for the local production of the vaccine with the first batch manufactured in April 2021.

Kazakhstan’s Karaganda pharmaceutical plant ready to manufacture Sputnik Light vaccine

By now, the Karaganda plant has manufactured five million doses of the Sputnik V vaccine.

Uzbekistan produces first batch of Sputnik V vaccine

At the first stage, the vaccine will be produced using raw materials from Russia, in the future a full cycle of production from local components.

First batch of the Sputnik V vaccine produced in Vietnam

To date, Sputnik V has been registered in 68 countries with a total population of over 3.7 billion people, which is nearly half of the global population.

Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility

Catalent’s Anagni site is a world-class biologics and oral dose manufacturing facility that specializes in late-stage and commercial product launches.

Rapid growth characterizes production of china’s vaccines

More than 1.4 billion doses of vaccines have been administered in China, and the country has provided over 500 million doses of vaccines overseas to assist in the global fight against the pandemic.